Literature DB >> 8009226

Receptor and ligand domains for invasion of erythrocytes by Plasmodium falciparum.

B K Sim1, C E Chitnis, K Wasniowska, T J Hadley, L H Miller.   

Abstract

A 175-kilodalton erythrocyte binding protein, EBA-175, of the parasite Plasmodium falciparum mediates the invasion of erythrocytes. The erythrocyte receptor for EBA-175 is dependent on sialic acid. The domain of EBA-175 that binds erythrocytes was identified as region II with the use of truncated portions of EBA-175 expressed on COS cells. Region II, which contains a cysteine-rich motif, and native EBA-175 bind specifically to glycophorin A, but not to glycophorin B, on the erythrocyte membrane. Erythrocyte recognition of EBA-175 requires both sialic acid and the peptide backbone of glycophorin A. The identification of both the receptor and ligand domains may suggest rational designs for receptor blockade and vaccines.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8009226     DOI: 10.1126/science.8009226

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  216 in total

1.  Analysis of human antibodies to erythrocyte binding antigen 175 of Plasmodium falciparum.

Authors:  D M Okenu; E M Riley; Q D Bickle; P U Agomo; A Barbosa; J R Daugherty; D E Lanar; D J Conway
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

2.  The adhesion of Plasmodium falciparum-infected erythrocytes to chondroitin sulfate A is mediated by P. falciparum erythrocyte membrane protein 1.

Authors:  J C Reeder; A F Cowman; K M Davern; J G Beeson; J K Thompson; S J Rogerson; G V Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

3.  Plasmodium falciparum erythrocyte invasion through glycophorin C and selection for Gerbich negativity in human populations.

Authors:  Alexander G Maier; Manoj T Duraisingh; John C Reeder; Sheral S Patel; James W Kazura; Peter A Zimmerman; Alan F Cowman
Journal:  Nat Med       Date:  2002-12-09       Impact factor: 53.440

4.  Independent translocation of two micronemal proteins in developing Plasmodium falciparum merozoites.

Authors:  Julie Healer; Simon Crawford; Stuart Ralph; Geoff McFadden; Alan F Cowman
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

5.  Invasion profiles of Brazilian field isolates of Plasmodium falciparum: phenotypic and genotypic analyses.

Authors:  Cheryl-Ann Lobo; Karla de Frazao; Marilis Rodriguez; Marion Reid; Mariano Zalis; Sara Lustigman
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

Review 6.  Functional analysis of erythrocyte determinants of Plasmodium infection.

Authors:  Amy K Bei; Manoj T Duraisingh
Journal:  Int J Parasitol       Date:  2012-04-19       Impact factor: 3.981

7.  Characterisation of PfRON6, a Plasmodium falciparum rhoptry neck protein with a novel cysteine-rich domain.

Authors:  Nicholas I Proellocks; Lev M Kats; David A Sheffield; Eric Hanssen; Casilda G Black; Karena L Waller; Ross L Coppel
Journal:  Int J Parasitol       Date:  2008-11-27       Impact factor: 3.981

8.  Identification of an erythrocyte binding peptide from the erythrocyte binding antigen, EBA-175, which blocks parasite multiplication and induces peptide-blocking antibodies.

Authors:  P H Jakobsen; P M Heegaard; C Koch; K Wasniowska; M M Lemnge; J B Jensen; B K Sim
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

9.  Using mutagenesis and structural biology to map the binding site for the Plasmodium falciparum merozoite protein PfRh4 on the human immune adherence receptor.

Authors:  Hyon Ju Park; Mara Guariento; Mateusz Maciejewski; Richard Hauhart; Wai-Hong Tham; Alan F Cowman; Christoph Q Schmidt; Haydyn D T Mertens; M Kathryn Liszewski; Dennis E Hourcade; Paul N Barlow; John P Atkinson
Journal:  J Biol Chem       Date:  2013-11-08       Impact factor: 5.157

10.  Advances and challenges in malaria vaccine development.

Authors:  Ruobing Wang; Joseph D Smith; Stefan H I Kappe
Journal:  Expert Rev Mol Med       Date:  2009-12-16       Impact factor: 5.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.